NDC 0002-7589
Bebtelovimab
Bebtelovimab
Bebtelovimab is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Eli Lilly And Company. The primary component is Bebtelovimab.
| Product ID | 0002-7589_4e804755-5920-440d-8e2c-7dc396e741de |
| NDC | 0002-7589 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Bebtelovimab |
| Generic Name | Bebtelovimab |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2022-02-11 |
| Marketing Category | EMERGENCY USE AUTHORIZATION / |
| Labeler Name | Eli Lilly and Company |
| Substance Name | BEBTELOVIMAB |
| Active Ingredient Strength | 88 mg/mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |